Genexine reports encouraging top-line results of the Phase 1b/2 clinical trial with GX-I7 (efineptakin alfa) in refractory or recurrent (R/R) metastatic Triple Negative Breast Cancer

SEOUL, South Korea--(BUSINESS WIRE)--Genexine (KOSDAQ: 095700) a publicly traded, clinical stage biopharmaceutical company committed to…

Fortinet Introduces Self-Learning AI Capabilities in New Network Detection and Response Offering

FortiNDR leverages machine learning and deep neural networks – the next-generation of AI – to…

Taiwan Placemaking Festival Makes Its Way to Taitung at the End of November; Magistrate Yao to Show Slow Economy to the World

TAITUNG, TAIWAN - Media OutReach - 7 June 2022 - The world's economic development professionals…

AIA Singapore partners with Franklin Templeton to introduce the first Shariah Balanced ILP fund in Singapore catering to a fast-growing Muslim consumer base

AIA Shariah Global Diversified Fund also expected to appeal to non-Muslim consumers keen on ethical…

Mitsubishi Electric to Establish New Factory in India for Factory Automation Control System Products

Increases production capacity in India to meet growing demand in local market TOKYO--(BUSINESS WIRE)--Mitsubishi Electric…

Toshiba Adds Five New MOSFET Gate Driver ICs that Will Help Reduce Device Footprints

- TCK42xG Series supports external back-to-back MOSFETs - KAWASAKI, Japan--(BUSINESS WIRE)--Toshiba Electronic Devices & Storage…

OPPO upgrades its Premium Service in Malaysia with the launch of Find X5 Pro

KUALA LUMPUR, MALAYSIA - Media OutReach - 7 June 2022 - Prioritizing user experiences has…

Chubb launches Individual Personal Accident and Group Personal Accident & Critical Illness Plans in Hong Kong SAR

HONG KONG SAR - Media OutReach - 7 June 2022 - Chubb announced the launch…